European Notebook: UK To Leave EU; Prices Attract Political Attention; Advanced Therapies Revamp
Executive Summary
Brexit vote creates uncertainty about biopharma policies in the UK and how local companies interact with the rest of the world;; antibiotic use decreases in several countries; high prices prompt European Commission review of industry incentives.